Quantum Healthy Longevity from Cells to Cities: Aging Biomarkers to Assess Interventions to Extend Human Healthspan and Resilience
|Thu. Feb. 29, 2024
UTC

No description

More videos

See more videos

Foundation Multiomics Models: Driven by Transcriptomics

Thu. Feb. 29, 2024

Non-Profits. The Longevity Pioneers

Thu. Feb. 29, 2024

Longaevus

Thu. Feb. 29, 2024

Clinical Trials in Prospera

Thu. Feb. 29, 2024

Targeting the Root Causes of Age-Related Diseases

Thu. Feb. 29, 2024

Longaevus

Thu. Feb. 29, 2024

Legal obstacles to longevity biotech and how we might go about removing them?

Thu. Feb. 29, 2024

Tales of the Molecular Garbage Man

Thu. Feb. 29, 2024

The Best of Both Worlds: Building a Biotech with Crypto That is Attractive to Traditional VC and Pharma

Thu. Feb. 29, 2024

Clinical Trials in Prospera

Thu. Feb. 29, 2024

Non-Profits. The Longevity Pioneers

Thu. Feb. 29, 2024

Foundation Multiomics Models: Driven by Transcriptomics

Thu. Feb. 29, 2024

Targeting the Root Causes of Age-Related Diseases

Thu. Feb. 29, 2024

Longaevus

Thu. Feb. 29, 2024

Legal obstacles to longevity biotech and how we might go about removing them?

Thu. Feb. 29, 2024

Tales of the Molecular Garbage Man

Thu. Feb. 29, 2024

The Best of Both Worlds: Building a Biotech with Crypto That is Attractive to Traditional VC and Pharma

Thu. Feb. 29, 2024

Clinical Trials in Prospera

Thu. Feb. 29, 2024

Non-Profits. The Longevity Pioneers

Thu. Feb. 29, 2024

Foundation Multiomics Models: Driven by Transcriptomics

Thu. Feb. 29, 2024

Foundation Multiomics Models: Driven by Transcriptomics

Thu. Feb. 29, 2024

Non-Profits. The Longevity Pioneers

Thu. Feb. 29, 2024

Longaevus

Thu. Feb. 29, 2024

Clinical Trials in Prospera

Thu. Feb. 29, 2024

Quantum Healthy Longevity from Cells to Cities: Aging Biomarkers to Assess Interventions to Extend Human Healthspan and ResilienceShareDownload|Thu. Feb. 29, 2024UTC

More videos

See more videos

Foundation Multiomics Models: Driven by Transcriptomics

Non-Profits. The Longevity Pioneers

Longaevus

Clinical Trials in Prospera

Targeting the Root Causes of Age-Related Diseases

Longaevus

Legal obstacles to longevity biotech and how we might go about removing them?

Tales of the Molecular Garbage Man

The Best of Both Worlds: Building a Biotech with Crypto That is Attractive to Traditional VC and Pharma

Clinical Trials in Prospera

Non-Profits. The Longevity Pioneers

Foundation Multiomics Models: Driven by Transcriptomics

Targeting the Root Causes of Age-Related Diseases

Longaevus

Legal obstacles to longevity biotech and how we might go about removing them?

Tales of the Molecular Garbage Man

The Best of Both Worlds: Building a Biotech with Crypto That is Attractive to Traditional VC and Pharma

Clinical Trials in Prospera

Non-Profits. The Longevity Pioneers

Foundation Multiomics Models: Driven by Transcriptomics

Foundation Multiomics Models: Driven by Transcriptomics

Non-Profits. The Longevity Pioneers

Longaevus

Clinical Trials in Prospera

Quantum Healthy Longevity from Cells to Cities: Aging Biomarkers to Assess Interventions to Extend Human Healthspan and Resilience
|Thu. Feb. 29, 2024
UTC